Two decades of progress in preventing vascular disease

Affiliations

Comment

Salim Yusuf. Lancet. 2002.

. 2002 Jul 6;360(9326):2-3.

doi: 10.1016/S0140-6736(02)09358-3.

¹ Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada L8L 2X2. yusufs@mcmaster.ca

No abstract available

Comment in

Heart Protection Study.
Trewby P. Trewby P. Lancet. 2003 Feb 8;361(9356):530; author reply 530. doi: 10.1016/S0140-6736(03)12476-2. Lancet. 2003. PMID: 12583970 No abstract available.

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Heart Protection Study Collaborative Group. Heart Protection Study Collaborative Group. Lancet. 2002 Jul 6;360(9326):7-22. doi: 10.1016/S0140-6736(02)09327-3. Lancet. 2002. PMID: 12114036 Clinical Trial.
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Heart Protection Study Collaborative Group. Heart Protection Study Collaborative Group. Lancet. 2002 Jul 6;360(9326):23-33. doi: 10.1016/S0140-6736(02)09328-5. Lancet. 2002. PMID: 12114037 Clinical Trial.